The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
Katrien EgerDora ParoczaiAlison M BaconFlorence SchleichSvetlana SergejevaArnaud BourdinIsabelle VachierEleftherios ZervasKonstantinos KatsoulisDimosthenis PapapetrouKonstantinos KostikasZsuzsanna CsomaEnrico HefflerGiorgio Walter CanonicaIneta GrisleKristina BieksieneJolita PalacionyteAnneke Ten BrinkeSimone HashimotoFrank W J M SmeenkGerrit J BraunstahlSimone van der SarFlorin MihălţanNatalia NenashevaMarina PeredelskayaBiljana ZvezdinIvan ČekerevacSanja HromišVojislav ĆupurdijaZorica LazicBranislava MilenkovicSanja Dimic-JanjicValentyna YasinskaBarbro DahlénApostolos BossiosNikolaos LazarinisDavid AronssonArne EgestenAbul Kashem Mohammad MunirLars AhlbeckChrister JanssonSabina ŠkrgatNatalija EdelbaherJoerg LeuppiFabienne JaunJochen RüdigerNikolay PavlovPietro GianellaReta FischerFlorian CharbonnierRekha ChaudhuriSteven James SmithSimon DoeMichelle FawdonMatthew MasoliLiam HeaneyHans Michael HaitchiRamesh KurukulaaratchyOlivia FultonBetty FrankemölleToni Gibson-LatimerKaren NeedhamPeter J HowarthRatko DjukanovicElisabeth BelMichael HylandPublished in: ERJ open research (2022)
Change to video/phone consultations and home administration of biologics was common in severe asthma care during the COVID-19 pandemic and was associated with high satisfaction levels in most but not all cases. Many physicians expect these changes to continue in future severe asthma care, though satisfaction levels may change after the pandemic.